# Pulmonx Reports Fourth Quarter and Full Year 2025 Financial Results
Canonical URL: https://biopharmsignal.com/news/LUNG/pulmonx-reports-fourth-quarter-and-full-year-2025-financial-results
Ticker: LUNG
Company: Pulmonx
Source: Pulmonx
Published: 2026-03-04 21:06 EST
Original Source URL: https://investors.pulmonx.com
## Summary

REDWOOD CITY, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today reported financial results for the fourth quarter and full year ended December 31, 2025.

## Article Body
REDWOOD CITY, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today reported financial results for the fourth quarter and full year ended December 31, 2025.
## Recent Company News
- 2026-07-15 20:05 EST — [Pulmonx to Report Second Quarter 2026 Financial Results on July 29, 2026](https://biopharmsignal.com/news/LUNG/pulmonx-to-report-second-quarter-2026-financial-results-on-july-29-2026-aba8edf7) — Source: Pulmonx
- 2026-06-01 20:05 EST — [Pulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/LUNG/pulmonx-corporation-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4) — Source: Pulmonx
- 2026-04-29 20:05 EST — [Pulmonx Reports First Quarter 2026 Financial Results](https://biopharmsignal.com/news/LUNG/pulmonx-reports-first-quarter-2026-financial-results) — Source: Pulmonx
- 2026-04-28 20:05 EST — [Pulmonx to Present at the Bank of America Securities 2026 Health Care Conference](https://biopharmsignal.com/news/LUNG/pulmonx-to-present-at-the-bank-of-america-securities-2026-health-care-conference) — Source: Pulmonx
- 2026-04-15 20:05 EST — [Pulmonx to Report First Quarter 2026 Financial Results on April 29, 2026](https://biopharmsignal.com/news/LUNG/pulmonx-to-report-first-quarter-2026-financial-results-on-april-29-2026) — Source: Pulmonx
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)